Faviprevir in COVID-19 treatment
Clinical Study Evaluating the Efficacy of Faviprevir in COVID-19 treatment
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
92
Favipiravir
chloroquine oral tablets
Tanta University, Ainshams University
Tanta, Egypt
Number of patients with mortality or need for mechanical ventilation
Number of patients with mortality or need for mechanical ventilation
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.